Results 141 to 150 of about 90,167 (303)
Efficacy and Safety Of Radiation Synovectomy with Yttrium-90 [PDF]
In this long term retrospective study of radiation synovectomy with Yttrium-90 (Y90), we evaluated the results of 164 applications in 82 patients with RA, OA with synovitis, ankylosing spondylitis and psoriatic arthritis.
Bozzone, P. +4 more
core
In a 12‐week randomized trial of 159 psoriasis patients, educational messages and treatment reminders delivered through Facebook improved treatment adherence, reduced disease severity, and enhanced quality of life. Three times‐weekly messages provided the greatest benefits, including superior adherence, clearer skin, and higher patient satisfaction ...
Jennifer Lavina T. Ngo +1 more
wiley +1 more source
Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives. [PDF]
Tofacitinib is an oral Janus kinase inhibitor approved for the treatment of psoriatic arthritis (PsA). It provides an alternative option for patients who have had an inadequate response and tolerance to other disease modifying antirheumatic drugs (DMARDs)
Beck, Kristen M +4 more
core
Linking the patient experience of foot involvement related to psoriatic arthritis to the International Classification of Functioning, Disability and Health [PDF]
Kate Carter +4 more
openalex +1 more source
Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis [PDF]
OBJECTIVES:\ud To assess, quantify and summarise the cost of illness of rheumatoid arthritis (RA) and ankylosing spondylitis (AS) from the societal perspective.\ud \ud METHODS:\ud Original studies reporting costs of RA or AS were searched systematically.
Ament, A.J.H.A. +4 more
core +2 more sources
High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors [PDF]
Carlos González‐Juanatey +5 more
openalex +1 more source
Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee +9 more
wiley +1 more source
Muhammad Haroon,1 Oliver FitzGerald,1 Robert Winchester2 1Department of Rheumatology, St Vincent's University Hospital, Dublin, Ireland; 2Division of Rheumatology, Columbia University College of Physicians and Surgeons, New York, NY, USA Abstract ...
Haroon M, FitzGerald O, Winchester R
doaj
Established Psoriatic Arthritis: Clinical Aspects [PDF]
Philip Helliwell
openalex +1 more source

